Pembrolizumab hits headlines as a key cancer immunotherapy advancing cures/vaccines, PD-1 blocker, Keytruda.
Prime Minister Benjamin Netanyahu has disclosed that doctors found a tiny, early-stage malignant tumor during routine follow-up after 2024 prostate surgery and that targeted radiation therapy has removed it. He has said he delayed publishing the report by two months to avoid fuelling Iranian misinformation during recent clashes. Doctors at Hadassah Medical Center have reported imaging and blood tests showing no remaining disease.